SCHEMBL726801

SCHEMBL726801

Cc1cnc(N)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2262531 0.72
SCHEMBL10021906 0.71 SMPD3 (0.48)
SCHEMBL112709 0.71
SCHEMBL4411570 0.71
SCHEMBL9662693 0.70
SCHEMBL162683 0.70
SCHEMBL4411566 0.69
SCHEMBL28539826 0.67
SCHEMBL16177862 0.67
SCHEMBL3445980 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114976047-B Catalyst for electro-oxidation of methanol and preparation method thereof 南京大学 2024-08-23 CN claimed
CN-114976047-A Catalyst for methanol electrooxidation and preparation method thereof 南京大学 2022-08-30 CN claimed
CN-108264507-A 6- phenethyl -4- hydroxyls -2(1H)The preparation method and applications of pyridone -3- carboxamides derivatives 北京大学 2018-07-10 CN claimed
US-20250368652-A1 MICROBIOCIDAL BICYCLIC HETEROCYCLIC CARBOXAMIDE DERIVATIVES SYNGENTA CROP PROTECTION AG (CH) 2025-12-04 US disclosed
EP-4638444-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE Bristol-Myers Squibb Company (US) 2025-10-29 EP disclosed
US-20250277156-A1 USE AND METHOD INNOSPEC LIMITED (GB) 2025-09-04 US disclosed
US-20250270463-A1 USE AND METHOD INNOSPEC LIMITED (GB) 2025-08-28 US disclosed
EP-4543882-A1 MICROBIOCIDAL BICYCLIC HETEROCYCLIC CARBOXAMIDE DERIVATIVES Syngenta Crop Protection AG (CH) 2025-04-30 EP disclosed
EP-4514924-A1 USE AND METHOD Innospec Limited (GB) 2025-03-05 EP disclosed
EP-4514925-A1 USE AND METHOD Innospec Limited (GB) 2025-03-05 EP disclosed
CN-119563008-A Use and method 因诺斯佩克有限公司 2025-03-04 CN disclosed
US-20070021472-A1 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility MILLENNIUM PHARMACEUTICALS, INC. 2007-01-25 US disclosed
US-20070021472-A1 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility MILLENNIUM PHARMACEUTICALS, INC. 2007-01-25 US disclosed
WO-2004100996-A1 VITRONECTIN RECEPTOR ANTAGONIST COMPOUNDS AND THEIR USE IN THE PREPARATION OF RADIOPHARMACEUTICALS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2004-11-25 WO disclosed
US-20040116399-A1 Inhibitors of factor Xa MILLENNIUM PHARMACEUTICALS, INC. 2004-06-17 US disclosed
US-20040116399-A1 Inhibitors of factor Xa MILLENNIUM PHARMACEUTICALS, INC. 2004-06-17 US disclosed
EP-0034924-B1 PROCESS FOR PREPARING 3-IODOMETHYL CEPHALOSPORINS ELI LILLY AND COMPANY (US) 1984-07-04 EP disclosed
EP-0034924-A2 Process for preparing 3-iodomethyl cephalosporins ELI LILLY AND COMPANY (US) 1981-09-02 EP disclosed
US-4266049-A Process for 3-iodomethyl cephalosporins ELI LILLY AND COMPANY (US) 1981-05-05 US disclosed
US-4006127-A Cationic diazacyanine dyestuffs BAYER AKTIENGESELLSCHAFT (DT) 1977-02-01 US disclosed